3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
2
Prostatic Neoplasms
1
Pancreatic Adenocarcinoma Resectable
1
Melanoma
1
Cholangiocarcinoma
1
Bile Duct Neoplasms
1
Interventions
Gemcitabine
6
Cisplatin
5
infigratinib
2
Platinum
2
Fluorouracil
2
1,2-diaminocyclohexaneplatinum II citrate
2
ricolinostat
1
niraparib
1
lenvatinib
1
galactomannan
1
fludarabine
1
famitinib
1
dostarlimab
1
atezolizumab
1
aldesleukin
1
Taxes
1
Standard of Care
1
Sildenafil Citrate
1
Sevoflurane
1
Photochemotherapy
1
Oxaliplatin
1
Observation
1
NVP-BKM120
1
Interviews as Topic
1
IMC-001
1
Electroporation
1
Desflurane
1
Cyclophosphamide
1
Carboplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Cholangiocarcinoma
×
Electroporation
×
Clear all
NCT04717687
2022-07-13
HOPE
Poitiers University Hospital
Phase NA
Withdrawn